Cattle Respiratory Disease Welfare and Prevention

Bovine respiratory disease is the most economically and welfare-significant disease complex in beef and dairy cattle, requiring proactive prevention and rapid treatment.

Key Facts

BRD accounts for over 75% of morbidity and 50% of mortality in beef feedlot cattle
Multiple viral and bacterial pathogens contribute including IBR, BVDV, PI3, Mannheimia and Pasteurella
Mixing, transport and weaning stress suppress immunity and increase disease susceptibility
Early treatment within the first 24 hours of clinical signs significantly improves recovery rates
Calves with BRD have chronic lung lesions detectable at slaughter even after clinical recovery
Metaphylaxis - treating all cattle at housing - reduces disease rates but raises antibiotic stewardship concerns
Vaccination programmes against viral pathogens reduce primary infection risk
Remote health monitoring systems including rumination sensors can detect disease earlier

Welfare Considerations

BRD causes significant suffering through fever, respiratory distress, reduced appetite and systemic illness. Chronic lung lesions from subclinical infection affect long-term health and welfare. Delayed treatment allows progressive lung damage. Welfare-centred BRD management combines risk reduction through vaccination and handling improvements with early clinical detection and prompt treatment. Antibiotic stewardship must balance welfare benefits of metaphylaxis against the public health importance of maintaining antibiotic efficacy.

What You Can Do

Support beef and dairy welfare standards requiring BRD monitoring and treatment protocols
Advocate for early treatment protocols that prioritise welfare over cost minimisation
Support development of rapid diagnostics that enable targeted antibiotic use
Engage with beef supply chains about BRD prevention programme requirements
Choose beef from farms with transparent health management and low mortality rates